Immune Systems Advisor

WHITE PAPER | VERSION 1.2 Prepared: 19 October 2026 Prepared by: OneDayMD Research Team Proposed programme: VAX-CAN Independent Research Programme Status: Concept paper for scientific review, ethics consultation and funding discussions A research proposal to investigate whether COVID-19 vaccination is associated with persistent cancer-related molecular signals, incident cancer diagnoses or objectively documented cancer progression. Proposed approach: A prospective, independently funded research programme combining a randomized biomarker study where ethically justified, longitudinal cancer surveillance, validated molecular assays and long-term clinical outcome assessment. Important statement of purpose This proposal does not assume that COVID-19 vaccines cause cancer, accelerate cancer growth or produce a phenomenon commonly called “turbo cancer.” It proposes a transparent study to investigate these questions using prespecified methods, appropriate...

By OneDayMD Editorial Team | Originally published May 2023 | Last updated October 2026 | Sources reviewed through October 2026 Quick Answer The FLCCC/IMA I-CARE Flu and RSV protocol is a home regimen of nasal and mouth antiseptics, supplements and off-label drugs. Most components are supported by laboratory or expert-opinion evidence, not influenza trials. The best-evidenced treatments for influenza are prescription antivirals started early: oseltamivir for hospitalized patients and baloxavir or oseltamivir for high-risk outpatients. Seek care promptly if you are high-risk or struggling to breathe. What changed in this update (October 2026) Fixed copy-paste wording that described the protocol as a COVID-19 guide. Replaced the claim that Tamiflu has “no antiviral properties.” Oseltamivir is a direct-acting neuraminidase inhibitor, and the 2025 paper is in JAMA Ne...